StreetInsider.com Top 10 News Items 7/28-8/1: Merrill, ImClone, Biogen/Elan, More...
More News related to BIIB
- InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc.
- Genentech and Biogen Idec Receive a Complete Response from the FDA for Rituxan for Chronic Lymphocytic Leukemia
- Biogen Idec to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
- Biogen Idec to Present at the 2009 Annual Credit Suisse Healthcare Conference
- Trading Outlook for MannKind Corp. Issued by InvestorSoup.com
More News related to BMY
- New Initiative: "Positive Charge" to Help Address Barriers and Provide Support to People Living with HIV/AIDS
- Notable 52-Week High's and Low's: BMY, JCG, PBR, SLW, GOOG, INCY, NTAP, QADI, GOLD, BONT Higher; SPWRB Low
- Asterand Announces Extension of Agreement with Bristol-Myers Squibb
- U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
- Barclays Maintains an 'Overweight' on Bristol-Myers (BMY); Raises PT
More News related to ELN
- Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference
- Elan Corporation Plc Announces Expiration of Tender Offer for 73/4% Senior Fixed Rate Notes Due 2011
- UBS Downgrades Elan (ELN) to Neutral
- Subset Data from Two Randomized Phase 3 Trials Show TYSABRI Significantly Reduces Rates of Hospitalization in Patients with Moderate-to-Severe Crohn's Disease
- Trading Outlook for Elan Corp. Plc. Issued by InvestorSoup.com
More News related to Special Reports
- Unusual 11 Mid-Day Movers 11/30: SOMX, CLWT, KBX, CSGS Higher; AIG, BGP, BONT, HEB Lower
- Notable ETF Movers: SLX, EWJ, USO Higher; UNG, XRT Lower
- Best of the Web 11/30: Some Banks So Bad Buyers Won't Touch 'Em, Risky Bets Hurt Harvard, Eurozone Inflation Turns Positive
- Notable Analyst Rating Changes for 11/30: X, DE, AFL, AEO Upgraded; BIDU, SWY, BKC, SVU Downgraded
- Morning Movers 11/30: PEIX, CLRT, PROV, SOMX, OTIV Higher; HPOL, MELA Lower
StreetInsider.com Top 10 News Items for the Week of July 28th - August 1st. This is a recap of this week's major news in the U.S. stock market.
1. Late Monday, Merrill Lynch (NYSE: MER) sold $30.6 billion gross notional amount of U.S. super senior ABS CDOs to an affiliate of Lone Star Funds for a purchase price of $6.7 billion. In addition, Merrill sold 380,000,000 shares of common stock for an aggregate amount of $8.55 billion. Shares of Merrill traded up 8% Tuesday following the news, although shares were off 11% on Monday ahead of the news.
2. On Thursday, Bristol-Myers Squibb Co. (NYSE: BMY) offered to acquire partner Imclone Systems (Nasdaq: IMCL) for $60 per share offer. Shares of Imclone traded up 38% on Thursday, above $60 per share, on hopes of a higher bid.
3. Late Thursday, Biogen Idec (Nasdaq: BIIB) and Elan Corporation (NYSE: ELN) disclosed two confirmed cases of progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS) patients treated with TYSABRI in the commercial setting. PML is a rare and often fatal brain disease. On Friday, shares of Biogen were down 25% and Elan was down 45%.
4. On Thursday, it was reported that U.S. Q4 GDP was revised to show a drop of 0.2%, versus the reported number of a 0.6% gain. The latest quarter (Q2) showed a gain of 1.9%.
5. On Friday, Nonfarm Payrolls were reported down 51K, versus the consensus of a 75K drop. The unemployment rate rose to 5.7%
6. The Federal Reserve extended the securities dealer loan programs through Jan 30. The also introduced 84-day Term Auction Facility (TAF) loans as a complement to 28-day TAF loans.
7. On Friday, General Motors (NYSE: GM) reports a Q2 adjusted loss of $11.21 per share, versus the consensus of a $2.62 loss. Revenues were $38.16 billion, versus the consensus of $44.57 billion. Shares of GM fell 5% on Friday.
8. On Tuesday, U.S. Steel Corporation (NYSE: X) reports Q2 EPS of $5.65, well above the analyst estimate of $3.91. Shares rose 10% on the week.
9. Visa (NYSE: V) and Mastercard (NYSE: MA) both reported strong Q2 results, but investors were concerned about slowing revenue growth. Visa is down 8% since reporting results. Mastercard is down 16% in that time.
10: Showing the strength in solar, sector leader First Solar, Inc. (Nasdaq: FSLR) reports Q2 EPS of $0.85, well above the analyst estimate of $0.58.
Related Categories
Special ReportsStocks Mentioned
+0.15
-0.99Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
